Tuo Xin Pharmaceuticals' wholly-owned subsidiary reaches cooperation with Henan Normal University in the research and development of anti-tumor and anti-viral new drugs.

On July 17th, the "Xinxiang City Deepening School-Enterprise Cooperation to Promote Industrial Innovation and Development Conference" was held. Tuo Xin Pharmaceutical, a wholly-owned subsidiary of the company, Xinxiang Pharmaceutical Co., Ltd., was invited to attend the conference and successfully reached a cooperation agreement with Henan Normal University on the research and development project of "Ankangfu Ding and other nucleoside antitumor and antiviral new drugs".